A step forward in de-escalating treatment The evolution of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has been shaped by the continuous challenge of balancing ...
People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, ...
Christian T. Ruff, MD, MPH, of Brigham and Women's Faulkner Hospital, discusses new data comparing abelacimab with ...
A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major ...
Patients who have a stent implanted to open a blocked coronary artery face dual risks of developing blood clots and of having ...
Three months of dual antiplatelet therapy after PCI may safely balance thrombosis and bleeding risk in both patients with low ...
A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor’s antiplatelet effects in patients ...
Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.
Sportschosun on MSN3d
Presenting the appropriate duration of medication after carotid stenting...Less than half a year is enough to reduce the risk of bleedingA is a graph comparing the occurrence of ischemic stroke and major bleeding (cerebral hemorrhage, intestinal hemorrhage ...
A study from the Karolinska Institutet in Sweden has found that some commonly used cardiovascular medications are linked to a ...
Tribune Content Agency on MSN5d
The Medicine Cabinet: Ask the Harvard Experts: The better names for blood thinnersQ: I was recently asked if I take a blood thinner. I wasn’t sure how to answer the question because I occasionally take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback